# Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

> **NCT00189787** · PHASE2 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 370 (actual)

## Conditions studied

- Asthma, Bronchial
- Bronchial Asthma

## Interventions

- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT00189787
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 370 (ACTUAL)
- **Last updated:** 2008-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189787, "Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00189787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*